---
trial_id: 732
discovery_date: 2022-04-24 16:23:21.899403
date: 2022-04-24 16:23:21.899403
title: "A multicenter, randomized, addition to baseline treatment, double-blind, placebo-controlled, Phase 3 study to evaluate the efficacy and safety of Satralizumab (SA237) in patients with neuromyelitis..."
summary: |
  <p>EudraCT Number: 2013-003752-21<br />Sponsor Protocol Number: BN40898(SA-307JG)<br />Sponsor Name: F. Hoffmann-La Roche Ltd.<br />Start Date: 2014-05-19<br />Medical condition: Neuromyelitis optica (NMO) and NMO spectrum disorder (MNOSD)<br />Disease: <br />Version: 20.0<br />SOC Term: 100000004852<br />Classification Code: 10029322<br />Term: Neuromyelitis optica<br />Level: LLT<br /><br />Population Age: Adolescents, Under 18, Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/GB">GB</a> (GB - no longer in EU/EEA), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/IT">IT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/PL">PL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/HU">HU</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/ES">ES</a> (Ongoing)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003752-21'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2013-003752-21<br />Sponsor Protocol Number: BN40898(SA-307JG)<br />Sponsor Name: F. Hoffmann-La Roche Ltd.<br />Start Date: 2014-05-19<br />Medical condition: Neuromyelitis optica (NMO) and NMO spectrum disorder (MNOSD)<br />Disease: <br />Version: 20.0<br />SOC Term: 100000004852<br />Classification Code: 10029322<br />Term: Neuromyelitis optica<br />Level: LLT<br /><br />Population Age: Adolescents, Under 18, Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/GB">GB</a> (GB - no longer in EU/EEA), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/IT">IT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/PL">PL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/HU">HU</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003752-21/ES">ES</a> (Ongoing)</p>